|Videos|August 3, 2020
Pharmaceutical CEO Leadership During the Pandemic
From COVID day-to-day management, to the future of the workforce In this segment, members of the, Pharmaceutical CEO Leadership During the Pandemic panel discuss the first order of business when restrictions began to how they envision employee safety and operations in the future.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
4
Beyond the Trial: How Integrating RWE and PROs is Redefining Treatment Success
5
